Latest Form 4 insider transactions

NASDAQ
Brian M. Jacoby, a Director of Midera Food Processing, Inc., reported multiple transactions in common stock on July 30, 2026.
NASDAQ
Kyle Featherstone, Chief Acct Officer, Controller of Huron Consulting Group Inc., sold 459 shares of common stock on July 31, 2026 for $152.67 per share.
NASDAQ
Thomas B Hagen, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
L Thomas Richards, a Director of Huron Consulting Group Inc., received 593 shares of common stock on August 1, 2026.
NASDAQ
Arne Blystad, a Director of Star Bulk Carriers Corp., purchased 7,580 shares of common stock on June 12, 2026.
OQX
Bonnie M Tompkins, a Director of MUNCY COLUMBIA FINANCIAL Corp, sold 120 shares of common stock on July 30, 2026 for $28.95 per share.
NASDAQ
William David Edwards, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
Robert A Nerbonne, a Director of Midera Food Processing, Inc., reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Jonathan Hirt Hagen, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
William P Forbes, EVP, Chief Development Officer of Heron Therapeutics, Inc. /De/, reported multiple transactions in common stock on July 30, 2026.
AMEX
Horizon Kinetics Asset Management Llc reported changes in beneficial ownership of RENN Fund, Inc. common stock on July 31, 2026.
NASDAQ
Dawn D Bugbee, a Director of Union Bankshares Inc, purchased 200 shares of common stock on July 27, 2026 for $23.30 per share.
NASDAQ
Luann Datesh, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
Jason Alexander Criqui, EVP, CBO of Northrim Bank of Northrim Bancorp Inc, sold 13,488 shares of common stock on July 31, 2026.
NASDAQ
Salvatore Correnti, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
Laura L Wells, a Director of Stock Yards Bancorp, Inc., sold 6,823 shares of common stock on July 30, 2026 for $86.29 per share.
NASDAQ
Frank E Jaumot, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.
NASDAQ
Eugene C Connell, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
Cheryl Yvonne Grenas, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.
NASDAQ
J Ralph Borneman Jr, a Director of Erie Indemnity Co, reported a transaction in 65 shares of common stock on July 31, 2026.
NASDAQ
Scott J Saunders, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.
OQX
Joseph Stilwell and 4 others reported changes in beneficial ownership of Peoples Financial Corp /Ms/ common stock on July 31, 2026.
Laura C Kendall, a Director of HomeTrust Bancshares, Inc., sold 10,000 shares of common stock on July 30, 2026 for $51.13 per share.
NASDAQ
Michael Lee Reed, a Director of Nutex Health, Inc., reported a transaction in 603 shares of common stock on July 31, 2026.
NYSE
Carlos G. Linares, EVP Chief Tech&Global New Prod of Church & Dwight Co Inc /De/, received 26 shares of common stock on July 31, 2026.
NASDAQ
Ira Duarte, EVP, Chief Financial Officer of Heron Therapeutics, Inc. /De/, reported multiple transactions in common stock on July 30, 2026.
NYSE
Richard A Dierker, President and CEO and a Director of Church & Dwight Co Inc /De/, received 44 shares of common stock on July 31, 2026.
NYSE
Brian D Buchert, EVP of Strategy, M&A, and BP of Church & Dwight Co Inc /De/, received 6 shares of common stock on July 31, 2026.
NASDAQ
Craig A Collard, Chief Executive Officer and a Director of Heron Therapeutics, Inc. /De/, reported multiple transactions in common stock on July 30, 2026.
NASDAQ
Christopher L Mapes, a Director of Nordson Corp, received 42 shares of common stock on July 31, 2026.